Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 369
5
Diseases
32
Unique genes
0.143
Avg. similarity score
Selective immunoglobulin a deficiency
Most-connected disease (4 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Selective immunoglobulin a deficiency
Selective iga deficiency disease
Microscopic colitis
joubert syndrome 3
IFIH1-related type 1 interferonopathy
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Selective immunoglobulin a deficiency | 4 | 4 | 3 |
| Selective iga deficiency disease | 3 | 3 | 31 |
| Microscopic colitis | 2 | 2 | 2 |
| joubert syndrome 3 | 2 | 2 | 1 |
| IFIH1-related type 1 interferonopathy | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| AHI1 | 3 / 5 | joubert syndrome 3, Selective iga deficiency disease, Selective immunoglobulin a deficiency |
| CLEC16A | 3 / 5 | Microscopic colitis, Selective iga deficiency disease, Selective immunoglobulin a deficiency |
| IFIH1 | 3 / 5 | IFIH1-related type 1 interferonopathy, Selective iga deficiency disease, Selective immunoglobulin a deficiency |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Allograft rejection | KEGG | 4 / 39 | 38.5× | 3.20e-6 | 1.31e-4 ✓ sig. |
| Type I diabetes mellitus | KEGG | 4 / 44 | 34.1× | 5.23e-6 | 1.97e-4 ✓ sig. |
| Graft-versus-host disease | KEGG | 4 / 45 | 33.4× | 5.73e-6 | 2.12e-4 ✓ sig. |
| Autoimmune thyroid disease | KEGG | 4 / 54 | 27.8× | 1.20e-5 | 3.89e-4 ✓ sig. |
| Inflammatory bowel disease | KEGG | 4 / 66 | 22.7× | 2.66e-5 | 7.54e-4 ✓ sig. |
| Th17 cell differentiation | KEGG | 4 / 109 | 13.8× | 1.90e-4 | 3.76e-3 ✓ sig. |
| Intestinal immune network for IgA production | KEGG | 3 / 50 | 22.5× | 3.09e-4 | 5.50e-3 ✓ sig. |
| Hepatitis B | KEGG | 4 / 163 | 9.2× | 8.74e-4 | 1.22e-2 ✓ sig. |
| Th1 and Th2 cell differentiation | KEGG | 3 / 93 | 12.1× | 1.89e-3 | 2.19e-2 ✓ sig. |
| Human T-cell leukemia virus 1 infection | KEGG | 4 / 224 | 6.7× | 2.81e-3 | 2.94e-2 ✓ sig. |
| Measles | KEGG | 3 / 139 | 8.1× | 5.89e-3 | 4.88e-2 ✓ sig. |
| cGMP-PKG signaling pathway | KEGG | 3 / 166 | 6.8× | 9.59e-3 | 6.69e-2 |
| JAK-STAT signaling pathway | KEGG | 3 / 168 | 6.7× | 9.90e-3 | 6.82e-2 |
| Virion - Adenovirus | KEGG | 1 / 4 | 93.8× | 1.06e-2 | 7.12e-2 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | Reactome | 1 / 4 | 93.8× | 1.06e-2 | 7.12e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| T cell differentiation | GO:0030217 | 4 / 54 | 43.3× | 2.11e-6 | 1.50e-4 ✓ sig. |
| positive regulation of immunoglobulin production | GO:0002639 | 3 / 33 | 53.1× | 2.40e-5 | 1.03e-3 ✓ sig. |
| immune response | GO:0006955 | 7 / 543 | 7.5× | 3.01e-5 | 1.22e-3 ✓ sig. |
| positive regulation of tissue remodeling | GO:0034105 | 2 / 6 | 195× | 4.24e-5 | 1.59e-3 ✓ sig. |
| positive regulation of B cell proliferation | GO:0030890 | 3 / 47 | 37.3× | 7.03e-5 | 2.33e-3 ✓ sig. |
| otic vesicle development | GO:0071599 | 2 / 8 | 146× | 7.90e-5 | 2.54e-3 ✓ sig. |
| regulation of B cell differentiation | GO:0045577 | 2 / 11 | 106× | 1.55e-4 | 4.19e-3 ✓ sig. |
| negative regulation of B cell apoptotic process | GO:0002903 | 2 / 11 | 106× | 1.55e-4 | 4.19e-3 ✓ sig. |
| T follicular helper cell differentiation | GO:0061470 | 2 / 11 | 106× | 1.55e-4 | 4.19e-3 ✓ sig. |
| positive regulation of T cell proliferation | GO:0042102 | 3 / 67 | 26.1× | 2.03e-4 | 5.10e-3 ✓ sig. |
| positive regulation of interleukin-4 production | GO:0032753 | 2 / 27 | 43.3× | 9.71e-4 | 1.47e-2 ✓ sig. |
| positive regulation of interleukin-17 production | GO:0032740 | 2 / 27 | 43.3× | 9.71e-4 | 1.47e-2 ✓ sig. |
| negative regulation of T cell receptor signaling pathway | GO:0050860 | 2 / 30 | 38.9× | 1.20e-3 | 1.69e-2 ✓ sig. |
| response to virus | GO:0009615 | 3 / 128 | 13.7× | 1.35e-3 | 1.80e-2 ✓ sig. |
| cochlea development | GO:0090102 | 2 / 35 | 33.4× | 1.63e-3 | 2.01e-2 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Selective iga deficiency disease | Selective immunoglobulin a deficiency | 0.094 | 3 | 7.39e-9 | 6.50e-8 ✓ sig. |
| IFIH1-related type 1 interferonopathy | Selective immunoglobulin a deficiency | 0.250 | 1 | 1.95e-4 | 5.28e-4 ✓ sig. |
| joubert syndrome 3 | Selective immunoglobulin a deficiency | 0.250 | 1 | 1.95e-4 | 5.28e-4 ✓ sig. |
| Microscopic colitis | Selective immunoglobulin a deficiency | 0.200 | 1 | 3.90e-4 | 8.52e-4 ✓ sig. |
| joubert syndrome 3 | Selective iga deficiency disease | 0.031 | 1 | 2.01e-3 | 2.89e-3 ✓ sig. |
| Microscopic colitis | Selective iga deficiency disease | 0.030 | 1 | 4.02e-3 | 5.08e-3 ✓ sig. |